These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5140587)

  • 1. [Physical and immunobiological characterization of anti-influenzal aerosol vaccine mixtures].
    Zardi O; Mammarella L; Adorisio E
    Nuovi Ann Ig Microbiol; 1971; 22(2):125-32. PubMed ID: 5140587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficency test of equine influenza vaccines on small laboratory animals].
    Mayr A; Thein P; Moll C
    Zentralbl Veterinarmed B; 1972 Jul; 20(5):325-39. PubMed ID: 4667977
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of some respiratory virus diseases with aerosols. II. Effectiveness of interferon and vaccine in influenzal infection].
    Sărăţeanu D; Babes VT; Demetrescu R; Danielescu G
    Stud Cercet Inframicrobiol; 1967; 18(6):433-9. PubMed ID: 5590424
    [No Abstract]   [Full Text] [Related]  

  • 4. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stimulation of influenza antibody formation following immunization with the use of ascitic tumor].
    Rukavishnikova GE; Alekseeva AK
    Biull Eksp Biol Med; 1975 Feb; 79(2):80-4. PubMed ID: 1093578
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological response of chickens, rabbits and guinea-pigs to equine influenza vaccines.
    Frerichs GN; Frerichs CC
    Res Vet Sci; 1973 Mar; 14(2):187-93. PubMed ID: 4805140
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Antibody response of hamsters to influenza vaccine following heterologous virus infection.
    Jennings R; Potter CW
    J Med Microbiol; 1973 Nov; 6(4):Pxx-xxi. PubMed ID: 4763980
    [No Abstract]   [Full Text] [Related]  

  • 8. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaxfectin, a cationic lipid-based adjuvant for protein-based influenza vaccines.
    Hartikka J; Bozoukova V; Yang CK; Ye M; Rusalov D; Shlapobersky M; Vilalta A; Wei Q; Rolland A; Smith LR
    Vaccine; 2009 Oct; 27(46):6399-403. PubMed ID: 19552895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
    Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice.
    Kaye HS; Dowdle WR; McQueen JL
    Am J Epidemiol; 1969 Aug; 90(2):162-9. PubMed ID: 5804363
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on live influenza virus vaccine. I. Attenuated influenza A2 Hong Kong virus and its biological and immunological characteristics (author's transl)].
    Izuchi T; Mizutani H
    Uirusu; 1973 Jun; 23(2):134-40. PubMed ID: 4808069
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity.
    Chen D; Burger M; Chu Q; Endres R; Zuleger C; Dean H; Payne LG
    Virus Res; 2004 Jul; 103(1-2):147-53. PubMed ID: 15163503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
    Noble S; McLain L; Dimmock NJ
    Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against influenza infection by cytokine-enhanced aerosol genetic immunization.
    Orson FM; Kinsey BM; Densmore CL; Nguyen T; Wu Y; Mbawuike IN; Wyde PR
    J Gene Med; 2006 Apr; 8(4):488-97. PubMed ID: 16389596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon in the anti-influenza protection provided by a mixtures of bacterial ribosomes and a membrane fraction of K. pneumoniae applied as an aerosol].
    Fontanges R
    Z Erkr Atmungsorgane; 1979 May; 153(2):241-9. PubMed ID: 94959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.